Policy / Pricing Medicare obesity drug pilot extended after insurer pushback PharmaphorumMedicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.Policy / PricingMetabolic & GLP-1Read full story pharminent April 22, 2026 (Last updated: April 22, 2026) Pharmaphorum Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part. Policy / PricingMetabolic & GLP-1Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Health Canada approves Biocon’s two denosumab biosimilarsNext: BioAegis and Prenosis partner for inflammatory disease therapies Related Stories Policy / Pricing Decoding Medicare Advantage Coding Intensity pharminent July 1, 2026 Policy / Pricing UK partners with Eli Lilly on obesity plan pharminent June 29, 2026 Policy / Pricing EFPIA report adds to pressures on EU drug pricing policy pharminent June 24, 2026
